Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells - A mini review

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 1, 2002, Pages 1-9

  Bortman, P ^a   Folgueira, M A A K ^a   Katayama, M L H ^a   Snitcovsky, I M L ^a   Brentani, M M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast tumor; Calcitriol; Calcitriol analog; Calcitriol receptor; Cell proliferation

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; ANGIOGENESIS INHIBITOR; CALBINDIN; CALCITRIOL; CALCIUM; CELL NUCLEUS RECEPTOR; CYCLOPHOSPHAMIDE; DIMER; DOXORUBICIN; ESTROGEN; GLUCOCORTICOID; LEXACALCITOL; OSTEOCALCIN; OSTEOPONTIN; OXYGENASE; PACLITAXEL; PHOSPHOPROTEIN; PROTEIN P21; RETINOID; RETINOID X RECEPTOR; SEOCALCITOL; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA2; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CELL; CALCIUM HOMEOSTASIS; CANCER INVASION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; FEMALE; GENE TARGETING; HEMATOPOIETIC CELL; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERCALCEMIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; VITAMIN D RESPONSIVE ELEMENT;

ANIMALIA;

EID: 0036184914     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2002000100001     Document Type: Article

References (60)

1. Vitamin D metabolism
2. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes
3. 3 and butyrate inducible responses
4. 3
5. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression
6. 3 24-hydroxylase
7. 3 leads to the induced differentiation of the myelomonocytic cell line U937
8. 3 response elements in the human transforming growth factor β2 gene
9. 3 receptor gene expression in cultured cells by serum and growth factors
10. 1,25-Dihydroxyvitamin-D-receptor in breast cancer cells
11. 3 receptors in T47D breast cancer cells
12. 3 binding activity during leukemic cell differentiation
13. Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-γ
14. Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest
15. 3 modulation of intracellular calcium during development of skeletal muscle cells in culture
16. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia
17. 3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex
18. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation
19. Vitamin D and breast cancer risk: The NHANES epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey
20. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
21. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases
22. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
23. 3-1α-hydroxylase in breast tissue
24. 3 binding in estrogen responsive rat breast tumor
25. 3
26. 3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)
27. 3, hypercalcemia, and growth suppression of 7,12-dimethylbenz(a) anthracene-induced rat mammary tumors
28. 5)
29. 3 receptor in breast carcinoma
30. 3 receptors in breast cancer and relationship to biochemical and clinical indices
31. Possible role for vitamin D in controlling breast cancer cell proliferation
32. Expression of vitamin D receptor and 24-hydroxylase genes in breast cancer
33. Growth suppression of normal mammary epithelial cells by wild type p53
34. Epidermal growth factor receptor, but not c-erb-2, activation prevents lactogenic hormone induction of β-casein gene in mouse mammary epithelial cells
35. 3 and modulation of its receptor
36. Regulação da expressão de RNAm de VDR e caracterização do envolvimento da via genômica e não genômica da vitamina D em células HC11 parentais ou transformadas com H-ras
37. HC11 mouse mammary cells are growth inhibited by EB1089 and KH1060 with a late induction of TGF-β expression while HC11 Ha-ras transformed cells are not affected by these compounds
38. 3 and its analogues on induction of apoptosis in breast cancer cells
39. 3 and its analogue, EB 1089, in human breast cancer cells
40. Kip1 gene promoter that lacks vitamin D response elements
41. 3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells
42. 3 and its analogs
43. 3, retinoic acid and dexamethasone
44. 3 inhibition of c-myc expression
45. 3 analogue EB1089
46. Antiproliferative action of vitamin D-related compounds and insulin-like growth-factor-binding protein 5 accumulation
47. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
48. 3 on breast and prostate cancer cells are associated with induction of BRCA gene expression
49. 3 analog, EB1089
50. 3 are events unrelated to growth arrest
51. WAF1/CIP1 or inhibition of c-myc expression
52. Topical calcipotriol treatment in advanced breast cancer
53. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer
54. 3 inhibits the invasive potential of human breast cancer cells in vitro
55. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells
56. 3 inhibits angiogenesis in vitro and in vivo
57. 3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells
58. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
59. 3 in mice
60. 3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo